Suppliers / Vifor (International)

Vifor (International)

Switzerland Updated 9 July 2026

Vifor (International) is an API and finished-dose manufacturer based in Switzerland. It appears in 196 regulatory filings across 24 regulators, without an active US DMF or CEP on file. Its filings concentrate with SWISSMEDIC (CH), EMA and DIGEMAPS (DO). Its GMP standing is certified by ANSM (FR), EMA and ANVISA (Brazil), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 6 September 2024 as VAI.

0
active US DMFs
0
valid CEPs
7
registered plants 1 with an FDA FEI number
196
filings across 24 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 6 September 2024 VAI US FDA
  • 22 January 2016 NAI US FDA
  • 15 November 2012 NAI US FDA
  • 15 April 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
St. Gallen, United Arab Emirates Not on file
92042 PARIS LA DEFENSE, United Arab Emirates Not on file
ST. GALLEN, Switzerland Not on file
Saint Gall, Switzerland Not on file
Switzerland, Switzerland 3002808450
Paris La Defense Cedex, France Not on file

1 further sites are on record.

What they file, and where

Molecule Regulators Docs
Ferric Carboxymaltose SFDA (Saudi Arabia) 1
Iron Sucrose PMDA (Japan) 1
カルボキシマルトース第二鉄 PMDA (Japan) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
SWISSMEDIC (CH) 59 None
EMA 23 3
DIGEMAPS (DO) 13 None
AIFA (IT) 12 None
UZPHARM (UZ) 10 None
INFARMED (PT) 9 None
ANSM (FR) None 3
ANVISA (Brazil) None 1
US FDA None 1

Comparing suppliers?

Choose your molecules and target markets. Vifor (International) comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 6 September 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates